期刊文献+

头颈癌生物标志物研究进展 被引量:1

Research Progress of Biomarkers for Head and Neck Cancer
下载PDF
导出
摘要 头颈癌的原发部位和病理类型之多,居全身肿瘤之首。由于缺乏有效的早期检测和风险评估手段,头颈癌患者的存活率较低,早期筛选和发现是改善患者存活率的关键。生物标志物的研究与应用为改善头颈癌早期诊断、分级、复发及预后评估等提供了重要手段。该文主要阐述头颈癌的影响因素和形成机制,并讨论目前已发现的头颈癌生物标志物,包括DNA甲基化、基质金属蛋白酶及细胞因子等。 The number of primary positions and pathological types of head and neck cancer is the largest in all cancers, but survival rate is relatively low for lack of early detection and risk evaluation. Early screening and detection are the keys for improving survival rate of head and neck cancer,and the study and application of biomarkers may provide approach to improve early diagnosis, grading, relapse and prognosis evaluation. Here is to elaborate the epidemiology and formation mechanism of head and neck cancer, and discuss the current biomarkers of head and neck cancer.ineluding methylation, matrix metallooroteinases and evtokines etc.
出处 《医学综述》 2014年第24期4458-4460,共3页 Medical Recapitulate
基金 国家自然科学基金(21277174)
关键词 生物标志物 头颈癌 DNA甲基化 基质金属蛋白酶 细胞因子 Biomarker Head and neck cancer Methylation Matrix metalloproteinases Cytokines
  • 相关文献

参考文献42

  • 1Schmitz S,Machiels JP.Molecular biology of squamous cell carcinoma of the head and neck relevance and therapeutic implications[J].Expert Rev Anticancer Ther,2010,10(9):1471-1484.
  • 2Schaaij-Visser TB,Brakenhoff RH,Leemans CR,et al.Protein biomarker discovery for head and neck cancer[J].J Proteomics,2010,73(10):1790-1803.
  • 3Lee KD,Lee HS,Jeon CH.Body fluid biomarkers for early detection of head andneck squamous cell carcinomas[J].Anticancer Res,2011,31(4):1161-1167.
  • 4Rezende TM,de Souza Freire M,Franco OL.Head and neck cancer:proteomic advances and biomarker achievements[J].Cancer,2010,116(21):4914-4925.
  • 5Thompson TL,Pageder NA,Karnell LH,et al.Factors associated with mortality in 2-year survivors of head and neck cancer[J].Arch Otolaryngol Head Neck Surg,2011,137(11):1100-1105.
  • 6Lewin F,Norell SE,Johansson H,et al.Smoking Tobacco,oral snuff,and alcohol in the etiology of squamous cell carcinoma of the head and neck[J].Cancer,1998,82(7):1367-1375.
  • 7Fakhry C,Gillisson ML.Clinical implications of human papillomavirus in head and neck cancers[J].J Clin Oncol,2006,24(17):2606-2611.
  • 8Gillison ML,D'Souza G,Westra W,et al.Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers[J].J Natl Cancer Inst,2008,100(6):407-420.
  • 9Mydlarz WK,Hennessey PT,Califano JA.Advances and perspectives in the molecular diagnosis of head and neck cancer[J].Expert Opin Med Diagn,2010,4(1):53-65.
  • 10Carvalho AL,Jeronimo C,Kim MM,et al.Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma[J].Clin Cancer Res,2008,14(1):97-107.

同被引文献3

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部